SNSW: Acetate Ganirelix Injection has obtained a drug registration certificate
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, SNSW announced that its wholly-owned subsidiary Chengdu SNSW Pharmaceutical Co., Ltd. recently received the "Drug Registration Certificate" issued by the National Medical Products Administration (referred to as "NMPA") for Acetate Ganirelix Injection. Acetate Ganirelix is used in women undergoing controlled ovarian stimulation (COS) protocols for assisted reproductive technology (ART) to prevent premature luteinizing hormone (LH) surges
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments